Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole

被引：23

作者：

Lupoli, G ^{[1
]}

Nuzzo, V ^{[1
]}

DiCarlo, C ^{[1
]}

Affinito, P ^{[1
]}

Vollery, M ^{[1
]}

Vitale, G ^{[1
]}

Cascone, E ^{[1
]}

Arlotta, F ^{[1
]}

Nappi, C ^{[1
]}

机构：

[1] UNIV NAPLES FEDERICO II,DEPT MOL & CLIN ENDOCRINOL & ONCOL,NAPLES,ITALY

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 1996年 / 10卷 / 05期

关键词：

hyperthyroidism; osteoporosis; biphosphonate; osteocalcin; bone mineral density;

D O I：

10.3109/09513599609012821

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

High levels of thyroid hormones accelerate bone turnover. The aim of the present study was to evaluate the effects of treatment with alendronate in patients affected by hyperthyroidism and osteoporosis. We studied 40 hyperthyroid patients with bone loss, divided into two groups according to menopausal state. Before treatment and after 6 and 12 months, serum 1 thyroid hormones levels, sevum osteocalcin level and bone mineral density were evaluated. In all patients we observed an increase in bone mineral density after treatment with alendronate, and a corresponding decrease in serum osteocalcin level.

引用

页码：343 / 348

页数：6

共 50 条

[21] Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures
Minisola, S
Pacitti, MT
Ombricolo, E
Costa, G
Scarda, A
Palombo, E
Rosso, R
MATURITAS, 1998, 29 (03) : 265 - 270
[22] Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
Felsenberg, D.
Bock, O.
Boerst, H.
Armbrecht, G.
Beller, G.
Degner, C.
Stephan-Oelkers, M.
Schacht, E.
Mazor, Z.
Hashimoto, J.
Roth, H-J.
Martus, P.
Runge, M.
JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (01) : 34 - 45
[23] Association between respiratory function and osteoporosis in pre- and postmenopausal women
Choi, JW
Pai, SH
MATURITAS, 2004, 48 (03) : 253 - 258
[24] The Beneficial Effect of Leisure-Time Physical Activity on Bone Mineral Density in Pre- and Postmenopausal Women
Kim, Kyee-Zu
Shin, Aesun
Lee, Jeonghee
Myung, Seung-Kwon
Kim, Jeongseon
CALCIFIED TISSUE INTERNATIONAL, 2012, 91 (03) : 178 - 185
[25] Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
Arlot, M
Meunier, PJ
Boivin, G
Haddock, L
Tamayo, J
Correa-Rotter, R
Jasqui, S
Donley, DW
Dalsky, GP
San Martin, J
Eriksen, EF
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1244 - 1253
[26] Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
Recker, Robert R.
Kendler, David
Recknor, Christopher P.
Rooney, Theodore W.
Lewiecki, E. Michael
Utian, Wulf H.
Cauley, Jane A.
Lorraine, Joanne
Qu, Yongming
Kulkarni, Pandurang M.
Gaich, Carol L.
Wong, Mayme
Plouffe, Leo, Jr.
Stock, John L.
BONE, 2007, 40 (04) : 843 - 851
[27] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
Aysegul Atmaca
Olcay Gedik
Advances in Therapy, 2006, 23 : 842 - 853
[28] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
Atmaca, Aysegul
Gedlik, Olcay
ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
[29] Correlation between bone mineral density and intervertebral disk degeneration in pre- and postmenopausal women
Nanjo, Y
Morio, Y
Nagashima, H
Hagino, H
Teshima, R
JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (01) : 22 - 27
[30] Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women
Wallace, BA
Cumming, RG
CALCIFIED TISSUE INTERNATIONAL, 2000, 67 (01) : 10 - 18

← 1 2 3 4 5 →